Symposium on Retinal Innovation

Symposium on Retinal Innovation

Speaking Engagement
A full-day event bringing together world leaders of translational research in drug development, regenerative therapies, gene replacement and other treatments for retinal degenerative diseases and AMD with leaders from the life sciences investment world.

WilmerHale Partner David Redlick will moderate a panel titled “Pharma Collaborations and Alliances.”

Read More About the Event

Speakers